Erythropoietin reduces the risk of exposure to allogeneic blood transfusion in THA and TKA
Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty.Vox Sang. 2016 Oct;111(3):219-225
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Seven randomized controlled trials were included in this systematic review and meta-analysis to determine the effectiveness of erythropoietin in reducing the risk of exposure to allogenic blood transfusions in patients undergoing total hip and knee arthroplasty procedures. Outcomes assessed were the incidence of allogeneic blood transfusion, units of allogeneic blood transfused, the incidence of a...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE